Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.71 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | MAOB | P27338 | 2/20 | 0.53 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | NPY1R | P25929 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12072717 | 0.86 | L3MBTL1 (0.60) | L3MBTL1MAPK1KDM4EMAOBAOC3 | |
| SCHEMBL12251531 | 0.85 | L3MBTL1 (0.55) | L3MBTL1MAPK1KDM4ETP53CYP3A4 | |
| SCHEMBL171811 | 0.85 | L3MBTL1 (0.68) | L3MBTL1KDM4EMAOBAOC3MAPT | |
| SCHEMBL2429378 | 0.84 | L3MBTL1 (0.66) | L3MBTL1KDM4EALDH1A1GAALMNA | |
| SCHEMBL8773193 | 0.83 | MAPK1 (0.61) | L3MBTL1MAPK1KDM4EMAPTALDH1A1 | |
| SCHEMBL30167649 | 0.82 | L3MBTL1 (0.55) | L3MBTL1KDM4EMAOBAOC3MAPT | |
| SCHEMBL5619009 | 0.82 | CYP3A4 (0.55) | L3MBTL1MAPK1KDM4ETP53CYP3A4 | |
| SCHEMBL29979999 | 0.82 | CYP3A4 (0.55) | L3MBTL1MAPK1KDM4ETP53CYP3A4 | |
| SCHEMBL22221774 | 0.82 | L3MBTL1 (0.64) | L3MBTL1KDM4EALDH1A1GAALMNA | |
| SCHEMBL11512115 | 0.82 | L3MBTL1 (0.56) | L3MBTL1MAPK1KDM4EMAOBAOC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023226102-A1 | DESIGN, PREPARATION AND USE OF NOVEL MACROLIDE | 上海彩迩文生化科技有限公司 | 2023-11-30 | — | — | WO | disclosed |
| US-20230337672-A1 | METHOD OF CONTROLLING SOYBEAN RUST FUNGUS HAVING RESISTANCE TO QoI FUNGICIDE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-10-26 | — | — | US | disclosed |
| US-20230337672-A1 | METHOD OF CONTROLLING SOYBEAN RUST FUNGUS HAVING RESISTANCE TO QoI FUNGICIDE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-10-26 | — | — | US | disclosed |
| US-20230232827-A1 | METHOD FOR CONTROLLING SOYBEAN RUST FUNGUS RESISTANT TO QoI FUNGICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-07-27 | — | — | US | disclosed |
| US-20230148061-A1 | TEAD INHIBITORS AND USES THEREOF | THE EHE FOUNDATION | 2023-05-11 | — | — | US | disclosed |
| EP-3461484-B9 | DIMESYLATE SALTS OF 4-(3-AMINO-1-(ISOQUINOLIN-6-YLAMINO)-1-OXOPROPAN-2-YL)BENZYL, THEIR COMBINATIONS WITH PROSTAGLANDINS AND THE USE THEREOF IN THE TREATMENT OF OCULAR DISORDERS | AERIE PHARMACEUTICALS INC (US) | 2021-06-09 | — | — | EP | disclosed |
| US-20210093618-A1 | SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF | GENENTECH, INC. (US) | 2021-04-01 | — | — | US | disclosed |
| CN-105916843-B | Octahydrocyclopenta [ c ] pyrrole selective NR2B negative regulator | 科登特治疗公司 | 2019-09-20 | — | — | CN | disclosed |
| EP-2970303-B3 | SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF | HYDRA BIOSCIENCES INC (US) | 2018-08-01 | — | — | EP | disclosed |
| US-10000483-B2 | Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereof | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2018-06-19 | — | — | US | disclosed |
| WO-2007127639-A2 | PRODRUG DERIVATIVES OF ACIDS USING ALCOHOLS WITH HOMOTOPIC HYDROXY GROUPS AND METHODS FOR THEIR PREPARATION AND USE | AERIE PHARMACEUTICALS, INC. (US) | 2007-11-08 | — | — | WO | disclosed |
| US-20070254920-A1 | Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use | AERIE PHARMACEUTICALS, INC. (US) | 2007-11-01 | — | — | US | disclosed |
| CN-1300073-C | Preparation method of 3,3'-di(trifluouro methyl) phenyl methane | SHISIHEWEI CHEMICAL CO LTD SHA (CN) | 2007-02-14 | — | — | CN | disclosed |
| US-7070838-B2 | Liquid crystalline compound, liquid crystal composition and their polymers | CHISSO PETROCHEMICAL CORPORATION (JP) | 2006-07-04 | — | — | US | disclosed |
| CN-1651372-A | Preparation method of 3,3'-di(trifluouro methyl) phenyl methane | SHISIHEWEI CHEMICAL CO LTD SHA (CN) | 2005-08-10 | — | — | CN | disclosed |
| US-20050007541-A1 | Liquid crystalline compound, liquid crystal composition and their polymers | JNC PETROCHEMICAL CORPORATION (JP) | 2005-01-13 | — | — | US | disclosed |
| EP-0511826-B1 | Phosphosulfonate herbicides | ROHM & HAAS (US) | 1997-07-16 | — | — | EP | disclosed |
| US-5500405-A | Phosphosulfonate herbicides | ROHM AND HAAS COMPANY (US) | 1996-03-19 | — | — | US | disclosed |
| US-5272128-A | Phosphosulfonate herbicides | ROHM AND HAAS COMPANY (US) | 1993-12-21 | — | — | US | disclosed |
| EP-0511826-A2 | Phosphosulfonate herbicides | ROHM AND HAAS COMPANY (US) | 1992-11-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230148061-A1 | TEAD INHIBITORS AND USES THEREOF | TEAD2, TEAD3, TEAD4 | L3MBTL1 3224/4885MAPK1 2346/4885KDM4E 972/4885 |
| US-10000483-B2 | Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereof | BMX, MELK, TEC | L3MBTL1 2181/4885MAPK1 144/4885KDM4E 2317/4885 |
| US-20070254920-A1 | Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use | HCAR1, HCAR2, PAICS | L3MBTL1 4086/4885MAPK1 2182/4885KDM4E 3612/4885 |
| US-20210093618-A1 | SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF | BRIX1, RDX, SULT2A1 | L3MBTL1 3583/4885MAPK1 4465/4885KDM4E 2167/4885 |
| US-20230337672-A1 | METHOD OF CONTROLLING SOYBEAN RUST FUNGUS HAVING RESISTANCE TO QoI FUNGICIDE | CYC1, SQOR, MT-CO1 | L3MBTL1 1545/4885MAPK1 1718/4885KDM4E 1417/4885 |
| US-20230232827-A1 | METHOD FOR CONTROLLING SOYBEAN RUST FUNGUS RESISTANT TO QoI FUNGICIDES | CYC1, SQOR, MT-CO3 | L3MBTL1 1321/4885MAPK1 2140/4885KDM4E 2624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.